Schrödinger, Inc. (Nasdaq: SDGR) announced its participation in three investor conferences in March 2026: the TD Cowen 46th Annual Health Care Conference, Leerink Global Healthcare Conference 2026, and KBCM Healthcare Forum. Management will hold fireside chats at each event, accessible live and archived on Schrödinger’s investor relations website. The company pioneers molecular discovery with its computational platform for drug development and materials design.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Schrödinger to Participate in Upcoming Investor Conferences
Schrödinger, Inc. (Nasdaq: SDGR) announced its participation in three investor conferences in March 2026: the TD Cowen 46th Annual Health Care Conference, Leerink Global Healthcare Conference 2026, and KBCM Healthcare Forum. Management will hold fireside chats at each event, accessible live and archived on Schrödinger’s investor relations website. The company pioneers molecular discovery with its computational platform for drug development and materials design.